...
首页> 外文期刊>Iranian red crescent medical journal >Association of Different MRI BIRADS Descriptors With Malignancy in Non Mass-Like Breast Lesions
【24h】

Association of Different MRI BIRADS Descriptors With Malignancy in Non Mass-Like Breast Lesions

机译:非肿块样乳腺病变中不同MRI BIRADS描述符与恶性的关系

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Several studies on the diagnostic efficacy of MRI has not real consensus for the accuracy of MRI characteristics in non mass like breast lesions, and the number of malignant lesions in different studies is insufficient. Objectives: In this study we aimed to analyze the diagnostic role of MRI BIRADS features for diagnosis of malignancy in non mass like breast lesions. Patients and Methods: All patients with positive findings (BIRADS 3, 4, 5), which had either biopsy proved pathology or follow-up MRI data at least for 12 months were included in the study. Finally, 213 breasts MRI that showed non mass like enhancing lesions among our patients were assessed in study. One experienced breast radiologist who was unaware of any clinical information or the histopathologic diagnosis evaluated all images retrospectively. The morphologic parameters evaluated consisted of distribution modifiers and pattern of internal enhancement. The kinetic enhancement parameters were assessed as showing washout, plateau, or persistent patterns. In the enhancement kinetic analysis, the most worrisome curve type in each lesion was considered for interpretation, if it was more than 2% enhancement. We have evaluated the visual findings by comparison of the signal intensity on the first and third dynamic series. Data for the study were extracted from the breast MRI database and analyzed using SPSS version 16 statistical software. Results: Totally 188 patients had 213 non mass like lesions. Mean age of the patients was 44.9±8.3 years (24-63). Totally 46 of lesions were malignant (21.6%). The most common BIRADS score was 4 (116; 54.5%). The most prevalent feature of distribution, internal enhancement and curve type were focal (59.2%), clumped (27.2%) and washout (34.3%). Distribution of different subgroups of MR BIRADS features was different among benign and malignant lesions (All Pvalues < 0.05). Regarding association with malignancy, odds ratio of lesions with segmental or ductal linear distribution was 3.4 (95% CI=1.7-6.8), Clumped, Reticular and Dendritic internal enhancement was 2.5 (95% CI=1.3-5) and wash out curve type was 5.4 (95% CI=2.7-10.9). Sensitivity of higher MR BIRADS (4,5) for diagnosis of malignancy was 100%. Specificity of segmental or ductal linear distribution in diagnosis of malignancy was 81%. Specificity of BIRADS 5 for diagnosis of malignancy was 98%. In a multivariate logistic regression analysis for diagnosis of malignancy in which distribution, internal enhancement and curve type were considered as independent variables, distribution and curve type remained significant in the model while the internal enhancement showed a borderline P-value. Conclusions: Although in our study washout pattern was the most powerful indicator for malignant pathology in non mass like enhancing lesions, more studies with larger sample size needs in this regard.
机译:MRI诊断功效的几项研究尚未就乳腺等非肿块的MRI特征的准确性达成真正的共识,而且不同研究中的恶性病变数目还不足。目的:在这项研究中,我们旨在分析MRI BIRADS功能在诊断非肿块样乳腺病变中的恶性肿瘤中的诊断作用。患者和方法:所有活检(病理学证实为病理学或随访MRI数据至少12个月)为阳性(BIRADS 3、4、5)的患者均纳入研究。最后,在研究中评估了213例MRI表现出非肿块样病变的乳房MRI。一位不知道任何临床信息或组织病理学诊断的经验丰富的乳腺放射科医生对所有图像进行了回顾性评估。评价的形态学参数由分布修饰剂和内部增强模式组成。评估动力学增强参数为表现出冲刷,平稳或持续模式。在增强动力学分析中,如果每个病变的增强程度超过2%,则考虑将其解释为最令人担忧的曲线类型。我们通过比较第一和第三动态序列上的信号强度来评估视觉效果。从乳房MRI数据库中提取研究数据,并使用SPSS 16版统计软件进行分析。结果:总共188例患者有213例非肿块样病变。患者的平均年龄为44.9±8.3岁(24-63)。共有46个病变是恶性的(21.6%)。最常见的BIRADS得分是4(116; 54.5%)。分布,内部增强和曲线类型最主要的特征是病灶(59.2%),结块(27.2%)和冲刷(34.3%)。在良性和恶性病变之间,MR BIRADS特征的不同亚组分布均不同(所有P值<0.05)。关于恶性肿瘤,具有节段性或导管性线性分布的病变的优势比为3.4(95%CI = 1.7-6.8),丛集性,网状和树突状内部增强为2.5(95%CI = 1.3-5)且呈曲线型值为5.4(95%CI = 2.7-10.9)。较高的MR BIRADS(4,5)对恶性肿瘤的诊断敏感性为100%。节段或导管线性分布在诊断恶性肿瘤中的特异性为81%。 BIRADS 5诊断恶性肿瘤的特异性为98%。在用于诊断恶性肿瘤的多变量logistic回归分析中,将分布,内部增强和曲线类型视为独立变量,模型中的分布和曲线类型仍然很显着,而内部增强则显示了临界P值。结论:尽管在我们的研究中,洗脱模式是非肿块(如增强病变)中恶性病理的最有力指标,但在这方面还需要更多具有更大样本量的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号